Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ophthalmic Genet ; 40(2): 110-117, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30870047

RESUMO

BACKGROUND: Leber congenital amaurosis (LCA) and early-onset retinal dystrophy (EORD), are primary causes of inherited childhood blindness. Both are autosomal recessive diseases, with mutations in more than 25 genes explaining approximately ~70% of cases. However, the genetic cause for many cases remains unclear. Sequencing studies from genetically isolated populations with increased prevalence of a disorder has proven useful for rare variant studies, making Costa Rica an ideal place to study LCA/EORD genetics. MATERIALS AND METHODS: Twenty-eight affected children (25 LCA, three EORD) and their immediate family members, totaling 52 individuals (30 affected) from 22 families, were sequenced. Whole exome sequencing was performed on all affected individuals. Available parents were analyzed either by whole exome sequencing (WES) or Sanger sequencing to determine transmission. RESULTS: All affected individuals demonstrated compound heterozygous or homozygous mutations in known Inherited Retinal Disease (IRD) associated genes. Twelve variants were identified in at least one individual in three genes, RDH12, RPE65, and USH2A. Four recurrent RPE65 mutations were observed in 97% of individuals and 95% of families. All patients with LCA and two of the three individuals with EORD had biallelic mutations in RPE65; one child with EORD had a homozygous RDH12 mutation. CONCLUSIONS: These data suggest that the majority of LCA/EORD in Costa Rica is due to four founder mutations in RPE65 which have been maintained in this genetically isolated population. This finding is of great clinical significance due to the availability of gene therapy recently approved in the US and European Union for patients with biallelic RPE65 defects.


Assuntos
Mutação da Fase de Leitura , Amaurose Congênita de Leber/genética , Mutação de Sentido Incorreto , Distrofias Retinianas/genética , cis-trans-Isomerases/genética , Adolescente , Oxirredutases do Álcool/genética , Criança , Pré-Escolar , Costa Rica/epidemiologia , Eletrorretinografia , Feminino , Efeito Fundador , Humanos , Lactente , Amaurose Congênita de Leber/epidemiologia , Amaurose Congênita de Leber/fisiopatologia , Masculino , Prevalência , Retina/fisiopatologia , Distrofias Retinianas/epidemiologia , Distrofias Retinianas/fisiopatologia , Sequenciamento do Exoma
2.
PLoS One ; 12(5): e0178201, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28542539

RESUMO

Spider major ampullate silk fibers have been shown to display a unique combination of relatively high fracture strength and toughness compared to other fibers and show potential for tissue engineering scaffolds. While it is not possible to mass produce native spider silks, the potential ability to produce fibers from recombinant spider silk fibers could allow for an increased innovation rate within tissue engineering and regenerative medicine. In this pilot study, we improved upon a prior fabrication route by both changing the expression host and additives to the fiber pulling precursor solution to improve the performance of fibers. The new expression host for producing spidroin protein mimics, protozoan parasite Leishmania tarentolae, has numerous advantages including a relatively low cost of culture, rapid growth rate and a tractable secretion pathway. Tensile testing of hand pulled fibers produced from these spidroin-like proteins demonstrated that additives could significantly modify the fiber's mechanical and/or antimicrobial properties. Cross-linking the proteins with glutaraldehyde before fiber pulling resulted in a relative increase in tensile strength and decrease in ductility. The addition of ampicillin into the spinning solution resulted in the fibers being able to inhibit bacterial growth.


Assuntos
Materiais Biomiméticos , Fibroínas/biossíntese , Leishmania/metabolismo , Ampicilina/farmacologia , Antibacterianos/farmacologia , Materiais Biomiméticos/farmacologia , Reatores Biológicos , Western Blotting , Reagentes de Ligações Cruzadas/química , Escherichia coli , Fibroínas/química , Fibroínas/farmacologia , Fibroínas/ultraestrutura , Glutaral/química , Leishmania/genética , Indústria Manufatureira , Teste de Materiais , Microscopia Eletrônica de Varredura , Projetos Piloto , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacologia , Proteínas Recombinantes/ultraestrutura , Soluções , Resistência à Tração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...